Cancer BiologyEuropean Journal of Medicinal Chemistry ReportsPeer-reviewed
Integrative in silico and experimental identification of non-covalent UBE2N inhibitors enhancing PARP inhibitor sensitivity
Côme Ghadi, Shafi Ullah Khan, Léonie Ibazizene…·Jana Sopková‐de Oliveira Santos
The paper identifies two non-covalent UBE2N inhibitors, CERMN-2 and CERMN-16, which enhance PARP inhibitor sensitivity in ovarian cancer cells.
1 citation